-
Single-cell RNA-sequencing reveals that glioblastoma recapitulates a normal neurodevetlopmental hierarchy
Study
EGAS00001004422
-
The genomic landscape of primary cutaneous anaplastic large cell lymphoma (pcALCL)
Study
EGAS00001004429
-
Neuroblastoma relapse trio series from the AMC
Study
EGAS00001001183
-
Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma
Study
EGAS00001001190
-
Study of non-clear cell renal cell carcinoma
Study
EGAS00001000926
-
ctDNA monitoring using patient-specific sequencing and integration of variant reads - Lung cohort
Study
EGAS00001004447
-
Clinical outcomes in ctDNA-positive urothelial carcinoma patients treated with adjuvant immunotherapy
Study
EGAS00001004997
-
Comprehensive Transcriptional Analysis of Early Stage Urothelial Carcinoma using whole transcriptome sequencing
Study
EGAS00001001236
-
Initial whole genome sequencing of plasma cell neoplasms in First Responders exposed to the World Trade Center attack of September 11, 2001
Study
EGAS00001004467
-
Uterine leiomyoma: DNA methylation, chromatin activity and gene expression
Study
EGAS00001004499
-
DNA methylation and somatic mutations converge on cell cycle and define similar evolutionary histories in brain tumors
Study
EGAS00001001255
-
Institut Curie Neuroblastoma Whole Genome Sequencing Diagnosis Relapse
Study
EGAS00001001184
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma - RNA-seq
Study
EGAS00001004552
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma
Study
EGAS00001004564
-
Clinical Outcomes by Tumor Mutational Burden and Inflammatory Gene Expression With Combined Nivolumab and Ipilimumab or Monotherapy in Advanced Melanoma - CM066-WES
Study
EGAS00001004567
-
Genomic characterization of esophageal squamous cell carcinoma reveals critical genes underlying tumorigenesis and poor prognosis
Study
EGAS00001001723
-
Queensland Melanoma Genomic Biomarker Study
Study
EGAS00001004619
-
Growth Hormone (GH) -secreting Pituitary Adenoma
Study
EGAS00001001293
-
Genomic analysis of patient-derived xenograft models reveals intratumor-heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib
Study
EGAS00001004666
-
Clonal selection and double hit events involving tumor suppressor genes underlie relapse from total therapy
Study
EGAS00001001810
-
Integrated molecular analysis of adult T-cell leukemia/lymphoma
Study
EGAS00001001296
-
Tumor-derived cell lines as pharmacogenomic models to predict therapeutic vulnerabilities in hepatocellular carcinoma
Study
EGAS00001003536
-
Targeting FGFR1 for treatment of soft-tissue sarcoma (H021)
Study
EGAS00001001844
-
RNA-sequencing of adult T-cell leukemia/lymphoma samples
Study
EGAS00001003575
-
Cancer-Associated Mutations in Endometriosis without Cancer
Study
EGAS00001003576
-
Multiomic profiling of early-passage melanoma cell lines.
Study
EGAS00001004536
-
Multi-omics analysis of primary glioblastoma cell-lines shows recapitulation of pivotal molecular features of parental tumors
Study
EGAS00001001871
-
Phylogenetic evolution of metastatic melanoma.
Study
EGAS00001003582
-
Carcinoma of the oral tongue (OTSCC) genomic landscape characterisation
Study
EGAS00001001329
-
A somatic reference standard for cancer genome sequencing with COLO829
Study
EGAS00001001385
-
MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas
Study
EGAS00001004544
-
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients with Advanced Lung Adenocarcinoma
Study
EGAS00001004546
-
Glioblastoma_CRISPR_Screen
Study
EGAS00001001519
-
A comprehensive assessment of somatic mutation detection in cancer using whole genome sequencing
Study
EGAS00001001539
-
Whole genome sequencing of primary and metastatic Melanoma cases in an Australian cohort.
Study
EGAS00001001552
-
PSCP_mutation_analysis_in_hESCs
Study
EGAS00001001561
-
Mutational landscape of renal cell carcinoma with venous tumor thrombus
Study
EGAS00001001950
-
Super enhancers define regulatory subtypes and cell identity in neuroblastoma
Study
EGAS00001004551
-
Integrated genomic characterization of IDH1 mutant Glioma malignant progression
Study
EGAS00001001588
-
Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion genes
Study
EGAS00001001601
-
A Phase II Trial of High Dose Interleukin-2 and Multi-site Stereotactic Ablative Radiotherapy for Patients with Metastatic Renal Cell Carcinoma
Study
EGAS00001003605
-
Recapitulation of genetic predisposition to medulloblastoma in human neuroepithelial stem cells
Study
EGAS00001003620
-
Whole-genome landscape of adult T-cell leukemia/lymphoma
Study
EGAS00001005237
-
SCAT_osteosarcoma_sequencing
Study
EGAS00001000196
-
RNASeq of PDX and CDX tumours treated with ADC
Study
EGAS00001004562
-
BLUEPRINT DNA Methylation 450K data of mantle cell lymphoma
Study
EGAS00001001637
-
Spatial and Temporal Homogeneity of Driver Mutations in Diffuse Intrinsic Pointine Glioma
Study
EGAS00001001654
-
33 patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) had whole exome sequencing performed. Cells were sorted by FACSAria using CD138, CD19 and CD56 to obtain a pure abnormal plasma cell population. Generated somatic variants were compared to a previous study of 463 multiple myeloma patients.
Study
EGAS00001001658
-
Paired exome analysis in urothelial carcinoma
Study
EGAS00001001686
-
Whole exome sequencing on primary retinoblastoma tissues and matching lymphocyte DNA.
Study
EGAS00001001690
-
Identifying_Novel_Fusion_Genes_in_Myeloma
Study
EGAS00001000220
-
Histological Transformation and Progression in Follicular Lymphoma: a Clonal Evolution Study
Study
EGAS00001001709
-
Single-cell RNA sequencing on 5063 single T cells isolated from peripheral blood, tumour and adjacent normal tissues from six hepatocellular carcinoma patients.
Study
EGAS00001002072
-
UAMS Smoldering Myeloma Myeloma Sequencing
Study
EGAS00001003629
-
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing
Study
EGAS00001001736
-
Evolutionary Genome Analysis of Transformation into Small Cell Carcinomas from Lung Adenocarcinomas
Study
EGAS00001001757
-
Integrative multi-omic analyses of malignant pleural mesothelioma
Study
EGAS00001004812
-
HYPERMUTATION AND MALIGNANT PROGRESSION IN LOW-GRADE GLIOMA PATIENTS
Study
EGAS00001002368
-
Genetic landscape of pediatric Adrenocortical Tumor
Study
EGAS00001000257
-
ChIP Seq data of multiple myeloma and plasma cell leukaemia cell lines
Study
EGAS00001002414
-
Pilot study for Illumina TST170 NGS panel on cutaneous T cell lymphoma samples
Study
EGAS00001002567
-
Analysis of tumor periphery and center-specific mutations in renal cell carcinoma
Study
EGAS00001001784
-
Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis
Study
EGAS00001001788
-
RRBS MDACC Lung PreCancer
Study
EGAS00001004610
-
Single cell RNA sequencing of lung adenocarcinoma.
Study
EGAS00001003681
-
Targeted_gene_fusion_sequencing__Fus_seq__in_mesothelioma
Study
EGAS00001000390
-
A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma
Study
EGAS00001001805
-
Detecting and tracking circulating tumour DNA copy number profiles during first line chemotherapy in oesophagogastric adenocarcinoma
Study
EGAS00001003695
-
Characterization of patient-derived xenograft models of myxoid liposarcoma either sentitive or resistant to trabectedin
Study
EGAS00001003715
-
Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif
Study
EGAS00001003719
-
Cancer and germline exomes consisting of FASTQ paired-end reads from melanoma and lung cancer samples
Study
EGAS00001003723
-
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Study
EGAS00001000510
-
DNA Methylation loss coupled with mitotic cell division promotes immune evasion of tumours with high mutation load
Study
EGAS00001003731
-
Subtype specific progression from DCIS to invasive breast cancer
Study
EGAS00001001866
-
Tissue and plasma RNA from esophageal cancer and precursor lesions
Study
EGAS00001004939
-
Ultraviolet radiation drives mutations in a subset of mucosal melanomas
Study
EGAS00001004697
-
Genomics_of_acral_lentiginous_melanoma
Study
EGAS00001003740
-
CASCADE metastatic melanoma study
Study
EGAS00001004950
-
Targeted_sequencing_of_cylindroma_patients
Study
EGAS00001002708
-
Glioblastoma initiating cells are sensitive to histone demethylase inhibition due to epigenetic deregulation
Study
EGAS00001003750
-
whole-genome sequencing in 17 ESCC cases and whole-exome sequencing in 71 cases
Study
EGAS00001000709
-
DIPG RNA and exome sequencing
Study
EGAS00001004749
-
CAF-S3 subset in human breast and ovarian cancers
Study
EGAS00001003344
-
Gene expression profile of mesothelial-derived carcinoma-associated fibroblasts
Study
EGAS00001003747
-
NRG1 Fusions in KRAS Wild-type Pancreatic Cancer (H021)
Study
EGAS00001002759
-
Identification of rare germline variants in familial multiple myeloma
Study
EGAS00001004734
-
Growth Hormone (GH) -secreting Pituitary Adenoma
Study
EGAS00001003488
-
Dynamics of genome architecture and chromatin function during human B cell differentiation and neoplastic transformation
Study
EGAS00001004763
-
Targeted panel data for newly diagnosed myeloma patients.
Study
EGAS00001002859
-
Normal brain controls for ICGC PedBrain DNA methylation sequencing
Study
EGAS00001000909
-
RNAseq of 76 samples from Uveal Melanoma tumors
Study
EGAS00001002932
-
Genomics_of_acral_lentiginous_melanoma___RNAseq
Study
EGAS00001003758
-
Alveolar Rhabdomyosarcoma case report
Study
EGAS00001004828
-
The_contribution_of_POT1_variants_to_sporadic_melanoma_development
Study
EGAS00001001964
-
Identification of recurrent mutations in Cushing’s disease
Study
EGAS00001003029
-
Immune trajectory of response and adverse effect in immunotherapy-treated hepatocellular carcinoma
Study
EGAS00001004843
-
Whole genome and whole transcriptome sequencing of Hepatosplenic T Cell Lymphoma tumor.
Study
EGAS00001003775
-
Genetic analysis of HLA and immune escape genes in Diffuse Large B-cell Lymphoma
Study
EGAS00001005054
-
Mutational analysis of an oligoprogressive sarcomatoid hepatocellular carcinoma treated with an immune checkpoint inhibitor.
Study
EGAS00001005064
-
Melanoma_brain_metastases
Study
EGAS00001002107